Onxeo announces its financial calendar for 2016
Paris (France), Copenhagen (Denmark) – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announces its financial calendar for 2016:
- February 26, 2016 Full-year 2015 results
- April 6, 2016 General shareholders’ meeting (to be convened in Paris)
- April 28, 2016 Quarterly information as of March 31, 2016
- July 28, 2016 Consolidated accounts for the 1st half of 2016
- October 25, 2016 Quarterly information as of September 30, 2016
This financial calendar is for indicative purposes only and Onxeo could change its publication dates should it deem it necessary.